HC
HCW Biologics Inc.
HCWB · NASDAQ
$1.99 +17.75% (+$0.30)
1M -26.30%
Market Cap $691.8K
P/E Ratio -
Div. Yield -
ROE 142.16%
Bulios Fair Price
$2.46
23.6% upside
Current Price
$1.99
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HCWB is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.09x
P/S 0.10x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 58.04%
Rev. growth 79.94%
FCF growth N/A
Profitability
20 /100
Weak Net margin 73.22%
Op. margin 91.57%
FCF margin 180.58%
Quality
3 /100
Poor ROE 142.16%
ROA 18.39%
Asset turnover 0.25x
Debt
26 /100
High Current ratio 0.06x
Int. coverage -13.52x
Debt/Equity 0.88x
Stability
1 /100
Unstable Rev. volatility 44.16%
EPS volatility 717.74%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HCWB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hing C. Wong
Employees
35
Headquarters
Miramar
Upcoming events
12 NOV
Earnings
Upcoming earnings report